{"id":28556,"date":"2024-04-23T11:35:11","date_gmt":"2024-04-23T11:35:11","guid":{"rendered":"https:\/\/abujacityjournal.com\/livenews\/?p=28556"},"modified":"2024-04-23T11:35:11","modified_gmt":"2024-04-23T11:35:11","slug":"sophia-genetics-and-syndicate-bio-bring-liquid-biopsy-to-africa","status":"publish","type":"post","link":"https:\/\/abujacityjournal.com\/livenews\/2024\/04\/23\/sophia-genetics-and-syndicate-bio-bring-liquid-biopsy-to-africa\/","title":{"rendered":"SOPHiA GENETICS and Syndicate Bio Bring Liquid Biopsy to Africa"},"content":{"rendered":"
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n
\n

SOPHiA GENETICS, a prominent cloud-native healthcare software company, has joined forces with Syndicate Bio to introduce liquid biopsy technology to Africa. This partnership signifies a major advancement in cancer diagnostics across the continent.<\/p>\n

Based in Nigeria, Syndicate Bio will implement the MSK-ACCESS\u00ae assay powered by SOPHiA DDM\u2122, making it the first lab in Africa to utilize this cutting-edge technology. By incorporating liquid biopsy testing into their services, Syndicate Bio aims to broaden access to comprehensive genomic profiling for cancer patients throughout Africa.<\/p>\n

The collaboration between SOPHiA GENETICS, Memorial Sloan Kettering Cancer Center (MSK), and Syndicate Bio underscores a shared commitment to addressing health disparities and promoting precision medicine globally.<\/p>\n

Given the limited access to advanced diagnostics in Africa, especially with approximately one million new cancer cases annually, Syndicate Bio’s adoption of liquid biopsy technology represents a crucial step forward in providing innovative testing options to previously underserved patients.<\/p>\n

Dr. Abasi Ene-Obong, Founder of Syndicate Bio, expressed enthusiasm about the collaboration, emphasizing its potential to accelerate cancer treatment and research across Africa, starting in Nigeria.<\/p>\n

The MSK-ACCESS\u00ae assay powered by SOPHiA DDM\u2122 offers deep sequencing of 146 cancer-associated genes, enabling Syndicate Bio to generate comprehensive reports from small blood samples efficiently. This non-invasive approach streamlines patient monitoring and promotes the adoption of precision medicine in cancer care.<\/p>\n

Philippe Menu, Chief Medical Officer of SOPHiA GENETICS, highlighted the significance of this initiative in advancing global healthcare, noting that Syndicate Bio’s implementation of this solution will have a tangible impact throughout Africa, contributing to the creation of an extensive and comprehensive dataset.<\/p>\n

This partnership aligns with SOPHiA GENETICS’ mission to democratize data-driven medicine and extend access to advanced diagnostics to underserved populations. The collaboration with Syndicate Bio represents a significant stride forward in the fight against cancer in Africa.<\/p>\n

In late 2023, SOPHiA GENETICS, MSK, and AstraZeneca announced a partnership to expand access to MSK-ACCESS\u00ae powered by SOPHiA DDM\u2122 testing globally, including in underserved regions where access to testing remains limited.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SOPHiA GENETICS, a prominent cloud-native healthcare software company, has joined forces with Syndicate Bio to introduce liquid biopsy technology to Africa. This partnership signifies a major advancement in cancer diagnostics across the continent. Based in Nigeria, Syndicate Bio will implement the MSK-ACCESS\u00ae assay powered by SOPHiA DDM\u2122, making it the first lab in Africa to […]<\/p>\n","protected":false},"author":12,"featured_media":28557,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[180],"tags":[],"class_list":["post-28556","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-technology"],"aioseo_notices":[],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/abujacityjournal.com\/livenews\/wp-json\/wp\/v2\/posts\/28556","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/abujacityjournal.com\/livenews\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/abujacityjournal.com\/livenews\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/abujacityjournal.com\/livenews\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/abujacityjournal.com\/livenews\/wp-json\/wp\/v2\/comments?post=28556"}],"version-history":[{"count":3,"href":"https:\/\/abujacityjournal.com\/livenews\/wp-json\/wp\/v2\/posts\/28556\/revisions"}],"predecessor-version":[{"id":28582,"href":"https:\/\/abujacityjournal.com\/livenews\/wp-json\/wp\/v2\/posts\/28556\/revisions\/28582"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/abujacityjournal.com\/livenews\/wp-json\/wp\/v2\/media\/28557"}],"wp:attachment":[{"href":"https:\/\/abujacityjournal.com\/livenews\/wp-json\/wp\/v2\/media?parent=28556"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/abujacityjournal.com\/livenews\/wp-json\/wp\/v2\/categories?post=28556"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/abujacityjournal.com\/livenews\/wp-json\/wp\/v2\/tags?post=28556"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}